Charles River Laboratories | CRL - Des Atouts





Des Atouts Changement Date
Agilent USD 13.97B 902M 2026-06
Align Technology USD 6.52B 103.03M 2026-09
Bio-Rad Laboratories USD 10.78B 531.1M 2026-09
Bruker USD 5.83B 224.6M 2026-09
Cardinal Health USD 59.54B 2.24B 2026-09
Charles River Laboratories USD 7.45B 80.64M 2026-09
Cigna USD 157.64B 562M 2026-09
Concord Medical Services Hldg CNY 6.55B 186.1M 2025-12
CVS Health USD 258.08B 4.31B 2026-09
Danaher USD 93.28B 914M 2026-09
Dentsply International USD 5.19B 14M 2026-09
Elevance Health USD 127.8B 1.36B 2026-09
Humana USD 57.2B 1.92B 2026-06
Illumina USD 6.81B 162M 2026-09
Incyte USD 7.29B 585.39M 2026-09
Intrexon USD 73.16M 77.88M 2024-06
IQVIA Holdings USD 30.47B 593M 2026-09
Laboratory Of America USD 18.92B 392.3M 2026-09
Lakefront Biotherapeutics EUR 3.35B 21.24M 2026-06
Lonza CHF 18.97B 164M 2025-12
McKesson USD 92.32B 3.99B 2026-09
Merck EUR 52.69B 383M 2026-06
Mettler Toledo International USD 3.7B 24.53M 2026-09
Novartis USD 117.15B 4.88B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Quest Diagnostics USD 17.22B 282M 2026-09
Revvity USD 11.49B 555.49M 2026-09
Thermo Fisher Scientific USD 114.23B 1.06B 2026-09
United Therapeutics USD 7.03B 186M 2026-09
UnitedHealth USD 312.78B 3.06B 2026-09
Veradigm USD 1.5B 185.94M 2022-12
Waters USD 24.12B 636M 2026-09
West Pharmaceutical Services USD 4.06B 15.7M 2026-09